Latest filing published 22 Mar 2021 for VistaGen Therapeutics, Inc., €3,146.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Brian J. Underdown: trading record in brief
Brian J. Underdown has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Argos Therapeutics Inc and VistaGen Therapeutics, Inc. The record holds 6 filings, for trades running from 12 February 2014 to 19 March 2021.
On the market, this insider has only ever bought: 1 purchase, €238k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 option exercise.
On 22 March 2021 came the latest disclosure, an option exercise for €3,146 in VistaGen Therapeutics, Inc. The last purchase on record was published on 12 February 2014, which is 4,653 days ago. Most trades are made public on the day they happen. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Brian J. Underdown
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$1.50100.0% of flowCommon StockSEC:0001415889-21-001609:0
- 13,131 sharesCommon StockSEC:0001209191-14-009865:0
- 43,185 sharesCommon StockSEC:0001209191-14-009865:1
- 582,769 sharesCommon StockSEC:0001209191-14-009865:2
- 569,990 sharesCommon StockSEC:0001209191-14-009865:3
- 40,497 shares@ US$8.00Common StockSEC:0001209191-14-009865:4Canonical exit: 13 May 2014 (T+90)
6 of 6 declarations